78 results
8-K
EX-99.1
TVTX
Travere Therapeutics Inc
6 May 24
Travere Therapeutics Reports First Quarter 2024 Financial Results
4:05pm
transparency with respect to key financial metrics the Company uses in making operating decisions.
Investors should note that these non-GAAP
8-K
EX-99.1
TVTX
Travere Therapeutics Inc
15 Feb 24
Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
the ability of investors to compare its results from period to period and allows for greater transparency with respect to key financial metrics
8-K
EX-99.1
m9b1269bzf49430ni5g
7 Nov 23
Travere Therapeutics Reports Third Quarter 2023 Financial Results
4:04pm
8-K
EX-99.1
zsiht38
3 Aug 23
Travere Therapeutics Reports Second Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
ikhm0e8u2w
4 May 23
Travere Therapeutics Reports First Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
u0ett71 bkgm
27 Oct 22
Travere Therapeutics Reports Third Quarter 2022 Financial Results
4:17pm
8-K
EX-99.1
kijdivj2lf5zn
4 Aug 22
Travere Therapeutics Reports Second Quarter 2022 Financial Results
7:06am
8-K
EX-99.1
h3ymguty2pre4qtj2i
5 May 22
Travere Therapeutics Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
9ba5x4v8mkv0k
24 Feb 22
Travere Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
12:00am
8-K
EX-99.1
e2ciiso
28 Oct 21
Travere Therapeutics Reports Third Quarter 2021 Financial Results and Organizational Progress
4:23pm